• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC GUARDWIRE TEMPORARY OCCLUSION SYSTEM; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC GUARDWIRE TEMPORARY OCCLUSION SYSTEM; CATHETER, EMBOLECTOMY Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bradycardia (1751); Stroke/CVA (1770); Loss of consciousness (2418)
Event Date 11/23/2021
Event Type  Injury  
Manufacturer Narrative
Authors: takuma nishimoto, fumiaki oka, koki okazaki, hideyuki ishihara journal name: neuroradiology year: 2022 literature title: relationship between cerebral hyperperfusion syndrome and the immediate change of cerebral blood flow after carotid artery stenting evaluated by single-photon emission computed tomography literature reference: doi.Org/10.1007/s00234-021-02822-8.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was submitted for review titled: relationship between cerebral hyperperfusion syndrome and the immediate change of cerebral blood flow after carotid artery stenting evaluated by single-photon emission computed tomography.The aim of this study was to evaluate the immediate changes in cerebral blood flow (cbf) after carotid artery stenting (cas) and subsequent cbf changes in patients with cerebral hyper-perfusion (hp) using an i-imp spect.A total of 223 patients with chronic extracranial carotid artery stenosis who underwent cas were included in this study.Depending on the nature of the lesion, five types of embolic protection devices could be selected.One device that could be selected was distal balloon protection using percusurge guardwire (n=112).Other options were distal filter protection using a non mdt device (n=90); proximal balloon protection using non mdt device and distal balloon protection using percusurge guardwire (n = 12); proximal balloon protection using a non mdt device and distal filter protection using a non mdt device (n = 5); or proximal balloon protection using moma ultra (medtronic) and distal filter protection using a non mdt device (n=4).In most cases, a 3.0 or 3.5 mm balloon catheter was used to predilate the stenosis.Three types of stents were placed in the stenotic lesion, two of which were non mdt and one was a medtronic stent - protege (n = 20).Post-dilation was performed with a percutaneous transluminal angioplasty balloon for residual stenosis.When a distal balloon protection device was used, an aspiration catheter was used to remove debris from the treated vessel before the balloon was deflated and antegrade flow in the vessel was restored.The median total occlusion time was 9 min (8¿11 min).All patients received maintenance oral antiplatelet treatment starting on the day after the procedure.Of the 223 patients, 5 had cerebral hyper-perfusion (hp).Of the 5 patients with hp, 4 developed cerebral hyper-perfusion syndrome (chs), whereas none of the 218 patients without hp had development of chs.Of 4 patients with chs, case 1 experienced headache 4 hours after cas with a 59.2% quantitative increase in cbf.Case 2 had eye pain and deterioration of consciousness 2 hours after cas with a 53.7% increase in cbf.Case 3 had deterioration of consciousness with restlessness 1 day after cas, with a 79.7% increase in cbf.Case 4 experienced headache and ct showed intracerebral hemorrhage 2 days after cas with a 73.0% increase in cbf.Intraoperative hypotension occurred in 102 cases.Bradycardia occurred in 70 cases.Hypotension and hypertension at the end of cas were present in 27 and 21 cases respectively.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GUARDWIRE TEMPORARY OCCLUSION SYSTEM
Type of Device
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
MEDTRONIC, INC
37a cherry hill dr
danvers MA 01923
Manufacturer (Section G)
MEDTRONIC, INC
37a cherry hill dr
danvers MA 01923
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key14875287
MDR Text Key295047502
Report Number1220452-2022-00056
Device Sequence Number1
Product Code DXE
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K023878
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 06/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/15/2022
Initial Date FDA Received06/30/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age74 YR
Patient SexMale
-
-